Related Experiment Videos
On the TRAIL to apoptosis.
1Terry Fox Molecular Oncology Group, Lady Davis Institute for Medical Research, Jewish General Hospital, Department of Microbiology and Immunology, McGill University, 3755 Cote St. Catherine, Montreal, Que., Canada H3T 1E2.
Cytokine & Growth Factor Reviews
|December 19, 2002
Summary
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) shows promise as a cancer therapy by selectively inducing apoptosis in cancer cells. Understanding TRAIL and its receptor regulation is key to developing effective cancer treatments.
Area of Science:
- Cellular Biology
- Molecular Biology
- Cancer Research
Background:
- Apoptosis, or programmed cell death, is crucial in mammalian cells, initiated via death receptors or mitochondrial pathways.
- TNF-related apoptosis-inducing ligand (TRAIL) selectively induces apoptosis in tumor cells, unlike normal cells, highlighting its therapeutic potential.
- NF-kappa B transcription factors regulate TRAIL expression in lymphocytes.
Purpose of the Study:
- To explore the therapeutic potential of TRAIL in cancer treatment.
- To investigate the differential regulation of TRAIL death and decoy receptors in cancer cells.
- To understand the role of TRAIL signaling in tumor cell elimination.
Main Methods:
- Analysis of TRAIL and its receptor expression in cancer cell lines.
- Investigating the signaling pathways of TRAIL-R1/DR4, TRAIL-R2/DR5, TRAIL-R3/DcR1, and TRAIL-R4/DcR2.
- Review of existing literature on TRAIL pathway regulation by transcription factors like NF-kappa B.
Main Results:
- TRAIL preferentially induces apoptosis in cancer cell lines.
- Cancer cells often overexpress death receptors (TRAIL-R1/DR4, TRAIL-R2/DR5) compared to decoy receptors.
- NF-kappa B is a key regulator of TRAIL expression.
Conclusions:
- TRAIL signaling pathway is a promising target for cancer therapy.
- Differential expression of TRAIL receptors suggests specific regulatory mechanisms in cancer.
- Further research into TRAIL regulation and function can guide the development of novel cancer treatments.